Disease severity in adult patients of turkish ancestry with familial mediterranean fever living in Germany or Turkey. Does the country of residence affect the course of the disease?

Journal of Clinical Rheumatology

Volumn 19, Issue 5, 2013, Pages 246-251

  Giese, Arnd ^a   Örnek, Ahmet ^a   Kilic, Levent ^b   Kurucay, Mustafa ^a   Şendur, Süleyman Nahit ^b   Lainka, Elke ^c,d   Henning, Bernhard Ferdinand ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d AID NET Autoinflammatory Disorders (AID) in Children: Genetics Disease Mechanisms Diagnostic Marke   (Germany)

Author keywords

blood sedimentation; C reactive protein; environment; familial Mediterranean fever; Germany; severity of illness index; Turkey

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE;

ADULT; AMYLOIDOSIS; ARTHRITIS; ARTICLE; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GERMANY; HUMAN; IMMIGRATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; TREATMENT DURATION; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGE OF ONSET; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; COLCHICINE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GERMANY; GOUT SUPPRESSANTS; HUMANS; LINEAR MODELS; MALE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; TURKEY;

EID: 84881479786     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31829ce005     Document Type: Article

References (20)

1. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879-1885.
2. Consortium FF. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25-31.
3. Consortium TIF. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797-807.
4. Chae JJ, Cho YH, Lee GS, et al. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity. 2011;34:755-768.
5. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351:659-664.
6. Papadopoulos V, Giaglis S, Mitroulis I, et al. The population genetics of familial Mediterranean fever: a meta-analysis study. Ann Hum Genet. 2008;72:752-761.
7. Kisacik B, Yildirim B, Tasliyurt T, et al. Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study. Rheumatol Int. 2009;29:1307-1309.
8. Touitou I, Sarkisian T, Medlej-Hashim M, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007;56:1706-1712.
9. Ozen S, Aktay N, Lainka E, et al. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis. 2008;68:246-248.
10. Pras E, Livneh A, Balow JE Jr, et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998;75:216-219.
11. Plebani M, De Toni S, Sanzari MC, et al. The TEST 1 automated system: a new method for measuring the erythrocyte sedimentation rate. Am J Clin Pathol. 1998;110:334-340.
12. Yalcinkaya F, Ozcakar ZB, Tanyildiz M, et al. Familial Mediterranean fever in small children in Turkey. Clin Exp Rheumatol. 2011; 29(4 suppl 67):S87-S90.
13. Ureten K, Gonulalan G, Akbal E, et al. Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia. Rheumatol Int. 2010;30:911-915.
14. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84:1-11.
15. Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227-253.
16. Lainka E, Bielak M, Neudorf U, et al. Hereditary recurrent fever syndromes (HRF). A subgroup of autoinflammatory diseases (AID) [in German]. Monatsschr Kinderheilkd. 2012;160:756-763.
17. Mor A, Shinar Y, Zaks N, et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum. 2005;35:57-64.
18. Giese A, Kurucay M, Kilic L, et al. Quality of life in adult patients with familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence. Rheumatol Int. 2012. [Epub ahead of print].
19. Kallinich T, Wittkowski H, Keitzer R, et al. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever. Ann Rheum Dis. 2010;69:677-682.
20. Guz G, Kanbay M, Ozturk M. Current perspectives on familial Mediterranean fever. Curr Opin Infect Dis. 2009;22:309-315.